PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma. Tang S, Ni J, Chen B, Sun F, et al. BMC Cancer 2022;22:525.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang S, Ni J, Chen B, Sun F, et al. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma. BMC Cancer 2022;22:525.
PMID: 35534807